Abstract:
The present invention relates to novel azole-fused pyridinyl urea derivatives or pharmaceutically acceptable salts thereof, a preparation method thereof and a pharmaceutical composition for preventing or treating urotensin II receptor activity-related diseases containing the same as active ingredients. The azole-fused pyridinyl urea derivatives according to the present invention works as an antagonist to a U-II receptor, thereby being capable of preventing or treating U-II receptor activity-related diseases such as congestive heart failure, heart ischemia, myocardial infarction, cardiomegalia, myofibrosis cordis, coronary artery disease, arteriosclerosis, hypertension, asthma, kidney failure, diabetes, vascular inflammation, degenerative neuronal disease, stroke, pain, depression, mental illness, and cancer.